In conclusion, we have identified an extremely high frequency of genetic disruption affecting the KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in serous ovarian tumors, occurring predominantly through copy-number loss of RBX1. Here, CUL3 is linked to ovarian serous tumor.